--:--:--
⬤ MEDIUM 09 Sep 2026, 12:01 UTC

Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit

Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. — Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on […]
\
Terms of Service